abiraterone acetate and prednisone/dexamethasone with docetaxel
Metastatic castration sensitive prostate cancer (mCSPC).
Call for patient/clinician input open:
Call for patient/clinician input closed:
For the treatment of metastatic castration sensitive prostate cancer in combination with androgen deprivation therapy.